The industry assumption is that "DTC" means advertising, "creative" means advertising campaign-creative, and agency means advertising agency. Brands should stop viewing DTC as promotion at people and start thinking of it as engaging with people. Better to call it DFC-direct for consumer. As an industry, we need to wean ourselves off the 50-year-old advertising-centric model that was developed to sell consumer products on TV and in print. It is right to suggest to people: "Ask your doctor if brand X is right for you." But it's naive to think the first thing a person does when they have a health concern is to call a doctor. As marketers, we can no longer afford to underinvest in the Internet-the medium consumers have actively made part of their personal healthcare system-in favor of ads that consumers are actively trying to avoid most of the time.
The industry assumption is that "DTC" means advertising, "creative" means advertising campaign-creative, and agency means advertising agency. Brands should stop viewing DTC as promotion at people and start thinking of it as engaging with people. Better to call it DFC—direct for consumer. As an industry, we need to wean ourselves off the 50-year-old advertising-centric model that was developed to sell consumer products on TV and in print. It is right to suggest to people: "Ask your doctor if brand X is right for you." But it's naive to think the first thing a person does when they have a health concern is to call a doctor. As marketers, we can no longer afford to underinvest in the Internet—the medium consumers have actively made part of their personal healthcare system—in favor of ads that consumers are actively trying to avoid most of the time.
At present, a "big idea" in DTC is one that can be turned into a "good" TV spot. And the spot subsequently can be turned into an integrated campaign where all the "adlobs" (ad-like objects) match like a set of expensive luggage. In this pursuit, we overlook the fact that people use different media for different reasons. Effective integration means exploiting the unique features of each medium to engage the customer in an exchange they'll find meaningful and valuable. A truly "big idea" is one that has the legs to make the brand relevant and engaging across multiple platforms.
This is not to say that advertising can't play a critical role. But advertising and other agencies that were built for the purpose of creating ad campaigns should no longer be leading a brand's efforts to engage, educate, and motivate people to seek the treatment and care they need and deserve.
Digitas Health is a next-generation marketing agency. As the name implies, digital is a core marketing strategy, not a form of alternative media.
Telephone: 215-545-4444
E-mail: info@digitashealth.com
Web site: digitashealth.com
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to Start
October 30th 2024By demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.